• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. OPTIPAC 80 REFOBACIN BONE CEMENT R-3; ORTHOPAEDIC CEMENT, MEDICATED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. OPTIPAC 80 REFOBACIN BONE CEMENT R-3; ORTHOPAEDIC CEMENT, MEDICATED Back to Search Results
Catalog Number 4712500398-3
Device Problems Fracture (1260); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problem Failure of Implant (1924)
Event Date 09/10/2021
Event Type  Injury  
Manufacturer Narrative
This is a combination product (b)(4).Report source, foreign and health professional - event occurred in (b)(6).Concomitant medical products: list of associated products : item number 150372 item name oss cemented im stem 18x150 50 lot # 216090.Item number 150411 item name oss tibial poly bearing 14mm lot # 822750.Item number unknown item name unknown femoral component lot # unknown.Item number unknown item name unknown hinge assembly lot # unknown.Item number unknown item name unknown tibial tray and stem lot # unknown.The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It was reported, that a patient underwent revision due to loosening of the femoral cemented stem and wear with fracture of the polyethylene.The cement initially implanted was an optipac 80 refobacin bone cement r-3.
 
Manufacturer Narrative
This is a combination product (b)(4).G3 - report source, foreign, health professional - event occurred in belgium.The product analysis can't be performed as the product was not returned.The device manufacturing quality record indicate that the released product met all requirements to perform as intended.X-rays were provided and were reviewed by associate director research and development.He did not see any abnormality in the x-rays concerning cement.Radiologist x-rays review concluded for a possible radiolucency at the bone cement interface of the femoral component, with normal bone mineralization.No other complaint on revision was recorded on the batch since ever, and 1 other complaint on revision was recorded on the reference from (b)(6) 2018 to (b)(6) 2021.No other complaint on loosening was recorded on the batch since ever, and 1 other complaint on loosening was recorded on the reference from (b)(6) 2018 to (b)(6) 2021.According to available data, root cause of the event was unable to be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that a patient underwent a revision due to loosening of the femoral cemented stem and wear with fracture of the polyethylene.The cement involved is an optipac 80 refobacin bone cement r-3.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIPAC 80 REFOBACIN BONE CEMENT R-3
Type of Device
ORTHOPAEDIC CEMENT, MEDICATED
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
Manufacturer (Section G)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR   26903
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key12688377
MDR Text Key278108418
Report Number3006946279-2021-00184
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
Reporter Country CodeBE
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Catalogue Number4712500398-3
Device Lot Number812AA09210
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received10/05/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/27/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10 FOR ASSOCIATEDPRODUCTS.
Patient Outcome(s) Required Intervention;
-
-